Skip to main content
. 2016 Jun 25;7(30):47821–47830. doi: 10.18632/oncotarget.10291

Figure 4. Serum miR-143, miR-145, miR-194, miR-203, miR-205, miR-215 expression levels (2−ΔCT) in Barrett, CLO and Esophagitis groups.

Figure 4

Differences in miRNA expression between the different groups were considered significant when the p value was under 0.05 (*).